Profile

Image Unavailable
First Name: Barbara
Surname: McKenzie
Position: Lecturer
Telephone: +44 (0)1224 262588
Email:
Linkedin: LinkedIn Icon https://www.linkedin.com/pub/barbara-mckenzie/16/369/546
ORCID: ORCID Icon http://orcid.org/0000-0003-0409-908X

Connect via ResearchGate

Barbara is a lecturer at the School of Pharmacy and Life Sciences.

Her current research focuses on the development of an eye model for analysis of corneal drug transport and problem-based learning.

Duties and Responsibilities

  • Lecturer in Pharmaceutics.
  • Module coordinator for Drug Analysis and Toxicology.
  • Academic contact for timetabling of the MPharm course.
  • School Research Committee representative.
  • Reviewer for Pharmaceutical Development and Technology.

Academic Background

  • MPharm (Hons) in Pharmacy, RGU 2006.
  • PhD in Pharmaceutics, RGU 2011.

Research Interests

Her research interests include:

  • Ophthalmic drug delivery.
  • Pulmonary drug delivery.
  • Research into treatments for Nephropathic Cystinosis.

Current Research

Barbara's current research focuses on the development of an eye model for analysis of corneal drug transport. She is also conducting research into the impact of PBL as a teaching method.

Funding

  • April 2010, £800 travel bursary received from the UK Resource Centre for Women in Science, Engineering and Technology, for attendance at the Controlled Release Society's annual meeting and exposition in Portland, Oregon.
  • September 2010, £500 travel grant received from the Cystinosis Foundation UK, for travel to the CRS conference in Portland, Oregon.
  • April 2012, £150 travel grant received from The Robert Gordon University's Institute of Health and Welfare Research, for travel to the International Cystinosis Conference in Paris.
  • July 2015, £700 travel grant received from Sparks Children's Medical Research, for travel to the CRS conference in Edinburgh, Scotland.

Professional Memberships

  • Member of Royal Society of Chemistry

Publications

  1. Buchan B, Kay G, Heneghan A, Matthews KH, Cairns D. Gel formulations for treatment of the ophthalmic complications in cystinosis. International Journal of Pharmaceutics. 2010; 392, 1-2, p. 192-197.
  2. Buchan B, Kay G, Matthews KH, Cairns D. Suppository formulations as a potential treatment for nephropathic cystinosis. Journal of Pharmaceutical Sciences. 2012; 101, 10, p. 3729-3738.
  3. McKenzie B, Kay G. Eye gels for ophthalmic delivery. Expert review of Ophthalmology. 2015; 10(2), 127-133.
  4. McKenzie B, Kay G, Matthews K H, Knott RM., & Cairns D. The hen's egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine-containing gel: Quantification using Photoshop® and ImageJ. International Journal of Pharmaceutics. 2015; 490 (1–2), 1–

Teaching

Barbara teaches on a number of MPharm modules, including MDM and Therapeutic delivery. She supervises final year projects, and is also involved in the Drug Analysis and Toxicology elective module on the forensic program.